Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalibor Valik

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|January 4, 2018
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancerJosef Chovanec, Iveta Selingerova, Kristina Greplova, et al.
Oncology|March 20, 2014
Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluationRegina Demlova, Martina Mrkvicova, Jaroslav Sterba, et al.
Scientific Reports|December 7, 2023
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumorsKlara Vejmelkova, Petra Pokorna, Kristyna Noskova, et al.
Frontiers in Oncology|December 5, 2019
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing SarcomaLenka Fedorova, Peter Mudry, Katerina Pilatova, et al.
JCO Precision Oncology|June 14, 2022
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib DosingPetra Pokorna, Giannoula Lakka Klement, Alzbeta Vasikova, et al.
Therapeutic Advances in Medical Oncology|May 19, 2025
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trialRadka Lordick Obermannova, Iveta Selingerova, Regina Demlova, et al.
International Journal of Cancer|December 23, 2014
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinomaPatrick Reichl, Meng Fang, Patrick Starlinger, et al.
Frontiers in Oncology|November 12, 2019
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process OutcomeEva Hlavackova, Katerina Pilatova, Dasa Cerna, et al.
Frontiers in Medicine|January 23, 2024
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practiceRegina Demlova, Sarka Kozakova, Michal Rihacek, et al.
Oncotarget|May 26, 2016
Future paradigms for precision oncologyGiannoula Lakka Klement, Knarik Arkun, Dalibor Valik, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|January 4, 2018
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancerJosef Chovanec, Iveta Selingerova, Kristina Greplova, et al.
Oncology|March 20, 2014
Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluationRegina Demlova, Martina Mrkvicova, Jaroslav Sterba, et al.
Scientific Reports|December 7, 2023
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumorsKlara Vejmelkova, Petra Pokorna, Kristyna Noskova, et al.
Frontiers in Oncology|December 5, 2019
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing SarcomaLenka Fedorova, Peter Mudry, Katerina Pilatova, et al.
JCO Precision Oncology|June 14, 2022
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib DosingPetra Pokorna, Giannoula Lakka Klement, Alzbeta Vasikova, et al.
Therapeutic Advances in Medical Oncology|May 19, 2025
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trialRadka Lordick Obermannova, Iveta Selingerova, Regina Demlova, et al.
International Journal of Cancer|December 23, 2014
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinomaPatrick Reichl, Meng Fang, Patrick Starlinger, et al.
Frontiers in Oncology|November 12, 2019
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process OutcomeEva Hlavackova, Katerina Pilatova, Dasa Cerna, et al.
Frontiers in Medicine|January 23, 2024
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practiceRegina Demlova, Sarka Kozakova, Michal Rihacek, et al.
Oncotarget|May 26, 2016
Future paradigms for precision oncologyGiannoula Lakka Klement, Knarik Arkun, Dalibor Valik, et al.
Pageof 5